PRS 2010 Meeting & Preliminary Program
The 2010 meeting of the Perinatal Research Society will be held September 24-26, 2010 at the Park Hyatt Beaver Creek Resort and Spa in Avon, Colorado. Escape to the extraordinary Park Hyatt Beaver Creek Resort and Spa and experience a magnificent chateau-style Vail resort that incorporates the grandeur of its idyllic Colorado Rocky Mountain setting. Whether you’re embarking upon self renewal with an innovative water-based treatment at our Allegria Spa, taking in the surrounding splendor from the balcony of your suite-style accommodations or delving into culinary delights at our welcoming restaurants, our Park Hyatt sets the standard for year-round luxury Vail Colorado resort hotel destinations. Visit the Park Hyatt Beaver Creek website for more details.
The room list is now closed, if you need to make changes to your reservation, please call the PRS Office at (608) 265-5838 or email prsadmin@erp.wisc.edu
To ensure that attendance is recorded and to receive meeting materials, please be sure to check in with the Society staff upon arrival.

2010 Perinatal Research Society
41th Annual Meeting -Park Hyatt Beaver Creek Resort & Spa Avon, Colorado, United States |
| |
|
| Friday, Sept. 24 |
Event |
|
4:00 pm – 5:30 pm |
Council Meeting |
| |
|
|
4:00 pm – 6:00 pm |
Check-in and Registration |
| |
|
|
6:00 pm |
Welcome by PRS President
Marilyn J. Cipolla, PhD |
| |
|
|
6:15 pm |
MEAD JOHNSON LECTURER Richard Traystman, PhD Professor of Pharmacology Vice-Chancellor for Research University of Colorado, Denver "Animal Research Models in Translational Research – The Good, The Bad, and The Ugly"
Moderator: Marilyn J. Cipolla, PhD |
| |
|
|
7:15 pm - 8:15 pm |
Welcome Reception |
| |
|
|
8:15 pm |
Dinner |
| |
|
| |
|
| Saturday, Sept. 25 |
Event |
| 7:00 am - 8:00 am |
NICHD/ Young Investigator Breakfast
Uma Reddy, MD
NICHD (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
Pregnancy & Perinatology Branch
|
| |
|
|
7:00 am - 8:00 am
|
BREAKFAST
|
|
8:00 am
|
MARCH OF DIMES LECTURER
Olaf Dammann, D Med, MPH
Director of Clinical Research, Newborn Medicine
Tufts Medical Center
Floating Hospital for Children, Boston, MA
"Perinatal Infection, Inflamation, and the Pre-term Brain"
Moderator: Joyce Koenig, MD |
| |
|
|
9:00 am
|
NICHD LECTURER
David Bucci, PhD
Associate Professor
Department of Psychological and Brain Sciences
Dartmouth University
"Rodent Models of Developmental Psychopathology: Benefits,
Limitations, and New Directions"
Moderator: Pam Kling, MD |
| |
|
|
10:00 am |
BREAK |
| |
|
10:30 am
|
EARLY CAREER INVESTIGATOR SPEAKER PRESENTATIONS
Antonette Dulay, MD
Yale University School of Medicine
Michael Golding, PhD
Texas A & M University
Angel Luciano, MD
University of South Florida
Moderator: Marilyn Cipolla, PhD |
| |
|
|
11:30 am
|
ABBOTT NUTRITION LECTURER
Susan Vannucci, PhD
Research Professor of Neuroscience in Pediatrics/Newborn Medicine
Research Director, Division of Newborn Medicine
Department of Pediatrics
Weill Cornell Medical College
"Hypoxia-Ischemia in the Immature Brain - So different from the adult!”
Moderator: John Kingdom, MD |
| |
|
|
12:30 pm |
LUNCH
|
| |
|
2:30 pm |
BUSINESS MEETING |
| |
|
3:30 pm
|
LILEY LECTURER Kirk Conrad, MD
Professor of Physiology and OB/GYN
Co-Director of the Reproductive and Perinatal Biology Research Program Department of Physiology and Functional Genomics University of Florida - Gainesville "Unveling the Vasodlatory Actions and Mechanisms of Relaxin"
Moderator: Russ Anthony, PhD
|
| |
|
| 4:30 pm |
Break, Change for Dinner |
| |
|
| 5:30 pm |
Gather and Load Bus to 4 Eagle Ranch |
|
|
|
6:00 pm
|
DINNER - 4 EAGLE RANCH
|
| |
|
| 10:00 pm |
Depart from 4 Eagle Ranch / Return to Hotel |
| |
|
Sunday, Sept. 26 |
Event |
| |
|
|
7:00 am - 8:00 am |
YOUNG INVESTIGATOR Q & A BREAKFAST |
| |
|
|
7:00 am - 8:00 am |
BREAKFAST |
| |
|
|
8:00 am
|
Lisa Hornberger, MD
Professor of Pediatrics and OB/GYN Director, Fetal and Neonatal Cardiology WCMC Stollery Children's Hospital Edmonton, Alberta "Fetal Echocardiography: Insights in the Fetal Circulation and Evolution of Congenital Heart Disease"
Moderator: Denise Hemmings, PhD |
| |
|
|
9:00 am |
Irina Buhimnschi, MD
Associate Professor
Department of Obstetrics, Gynecology and Reproductive Sciences
Yale University
"Proteomics Approach to Predicting Pre-term Birth" Moderator: Marjorie Meyer |
| |
|
|
10:00 am |
BREAK |
| |
|
|
10:15 am
|
Elizabeth Bonney, MD
Professor and Director, Divison of Research
Department of Obstetrics, Gynecology and Reproductive Sciences
University of Vermont
"T Cell Homeostasis: A View of the Immune System During Pregnancy"
Moderator: Jeff Segar, MD |
| |
|
|
11:30 am |
ADJOURN
|
|
|
|
Speaker Bios
|
Back to Top
David Bucci, PhD
Dr. Bucci is an Associate Professor of Psychological and Brain Sciences at
Dartmouth
College
. He received his B.A. in Biology & Psychology with honors from
Wesleyan
University
and his Ph.D. in Neurobiology from
University
of
North Carolina
,
Chapel Hill
after which he did a Postdoctoral Fellowship at
Brown
University
in the Departments of Psychology and Neuroscience. Dr. Bucci’s research is focused on the behavioral and neurobiological factors that regulate learning and memory. One goal of this research is to further our understanding of the basic mechanisms of information processing in the brain. A second goal is to relate these findings to the biological basis of cognitive dysfunction and mental illness in humans. Dr. Bucci has received numerous honors and awards and is currently funded by NSF and NIH NIMH.
|
|
Back to Top
Irina Buhimschi, MD
Dr. Buhimschi is currently an Associate Professor in the Obstetrics, Gynecology and Reproductive Sciences at
Yale
University
. Her research interests span the broad area of understanding the determinism of preterm labor and preeclampsia syndromes. The current focus is in developing proteomic algorithms that can aid physicians in diagnosing early patients and make treatment decisions. Her research group has discovered several proteomic profiles that set apart preterm labor instances that could benefit from specific treatments such as that induced by inflammation/infection, bleeding or both. Novel protein biomarkers were also discovered in cerebrospinal fluid and urine of patients with preeclampsia that will be able to help clinicians in differentiating preeclampsia from other hypertensive proteinuric disorders of pregnancy. This work is funded by grants from the National Institutes of Health (NIH), Center for Disease Control (CDC) and March of Dimes.
|
|
Back to Top
Elizabeth Bonney, MD
Dr. Bonney is a board-certified Obstetrician and Gynecologist who is actively involved in patient care and is interested in the regulation of maternal immunity and in mucosal immunity in women. She received her medical school training at Stanford University School of Medicine. From there she did her internship and residency in a Harvard-affiliated OB/GYN residency program. To add to her training in basic immunology she became first a Medical Staff Fellow and then a Senior Staff fellow at the National Institutes of Health where she trained in both the Laboratory of Immunology and the Laboratory of Cellular and Molecular Immunology. She is currently an Associate Professor of Obstetrics, Gynecology and Reproductive Sciences at the University of Vermont College of Medicine and is also the head of the department’s Division of Reproductive Science Research. In addition, she is a member of the Graduate College Program in Cell and Molecular Biology, and the
Vermont
Center
for Immunology and Infectious Diseases. Her laboratory uses a mouse model of immunity to the male antigen H-Y and Lymphocytic Choriomeningitis Virus (LCMV) to determine the rules for regulation of immunity during pregnancy. Recently, she has begun work delineating the cellular factors important in a mouse model of preterm delivery. |
|
Back to Top
Richard J. Traystman, PhD
Dr. Traystman is Vice Chancellor for Research at the
University
of
Colorado Denver
. He is also a Professor of Pharmacology at the
School
of
Medicine
. He received his BS and MS degrees from
Long Island
University
and his PhD from
Johns
Hopkins
University
Medical
Center
. Following his postdoctoral fellowship at Bowman Gray School of Medicine, Traystman returned to
Johns
Hopkins
Medical
Center
in 1972 and remained there until 2003 as a Distinguished University Professor. In 2003, he was appointed Associate Vice President for Research, Planning and Development and Associate Dean for Research at Oregon Health & Sciences University where he was also a Professor of Anesthesiology and Peri-operative Medicine. Traystman was the sole editor-in-chief of the Journal of Cerebral Blood Flow and Metabolism from 2005-2009 and also serves on the editorial boards of several other prestigious journals and reviews manuscripts for a multitude of journals. He has been Associate Editor for the Heart and Circulatory section of the American Journal of Physiology and was deputy editor for Critical Care Medicine. Traystman has received numerous distinguished awards from both clinical and basic science organizations for his work. He has spent more than 35 years working on the regulation of brain blood vessels, cardiac arrest/cardiopulmonary resuscitation and stroke. He has written numerous articles on the appropriateness of animal models of disease for translation of basic findings to clinical studies. Traystman has published more than 450 articles in peer-reviewed journals, has trained more than 100 fellows and students and has been funded by NIH throughout his career. Currently, he is the President-elect for the International Society for Cerebral Blood Flow and Metabolism. |
Back to Top
Lisa Hornberger, MD
Dr. Hornberger is a Professor in the Department of Pediatrics and Director of Alberta Health Services' Fetal & Neonatology Cardiology Program at the WCMC Stollery Children's Hospital in
Edmonton
,
Alberta
. She has authored more than 100 articles and textbooks focused on the early diagnosis, evolution, management and outcomes of fetal heart disease. Dr. Hornberger's research interests are on the detection and correction of fetal heart complications. Her work has focused on the prenatal diagnosis, natural evolution, management and outcome of structural, functional and rhythm related cardiovascular disorders detected in utero. Dr. Hornberger collaborates extensively with clinical and basic scientists in the areas of perinatology, neonatology, radiology, pathology and physiology. The novel directions of her research may lead to improvements in diagnosis, but more importantly could pave the way to develop therapies that will ultimately improve outcomes for affected patients. |
|
Back to Top
Kirk P. Conrad, MD
Dr. Conrad is Professor of Physiology and Functional Genomics and of Obstetrics and Gynecology at the University of Florida College of Medicine where he also serves as Co-Director of the Reproductive and Perinatal Biology Research Program. Dr. Conrad received his undergraduate degree from
Bowdoin
College
in Biochemistry, graduating magna cum laude. He received his MD from
Dartmouth
College
. After completing a Medicine Internship at the University of Colorado Health Sciences, he completed 2 postdoctoral fellowships first at Dartmouth Medical School in Renal Physiology, Dept. of Physiology and then at Case Western Reserve in Cell Physiology in the Department of Nephrology. Dr. Conrad has been a faculty member of the Dept. of Physiology,
Dartmouth
Medical
School
(1984-1990); Depts. of Physiology and of Ob/Gyn, University of New Mexico School of Medicine (1990-94); and the Depts. of Ob/Gyn and Reproductive Sciences, Cell Biology and Physiology at the University of Pittsburgh School of Medicine, Magee Womens Research Institute (1994-2006). He has 63 original publications and 30 invited reviews and chapters, and holds several patents as primary inventor. Dr. Conrad is recipient of the 2010 Ernest H. Starling Distinguished Lectureship of the American Physiological Society Water and Electrolyte Homeostasis Section. He receives support from the NIH, March of Dimes, American Heart Association and the 8th Mallinckrodt Scholar Award. Dr. Conrad’s research is focused on the elucidation of the mechanisms underlying vasodilation and increased arterial compliance during normal pregnancy with emphasis on the hormone relaxin, vascular endothelial and placental growth factors, vascular MMP-2 and -9, endothelin1-32, the endothelial ETB receptor subtype, and nitric oxide. Dr. Conrad’s work also deals with the potential therapeutic benefit of relaxin in preeclampsia involving preclinical studies using two animal models of the disease. Other areas of investigation include the study of maternal cardiovascular adaptations to pregnancy in women who conceive by assisted reproductive technologies (ART), local relaxin ligand-receptor expression and function in arteries, the need cardiovascular homeostasis in vivo, and the role of the placenta and trophoblast cells in the pathogenesis of preeclampsia. |
|
Back to Top
Olaf Dammann, DrMed, MPH
Dr. Dammann is a pediatrician and epidemiologist with a doctorate from Hamburg University (Germany, ’91) and a Master’s degree from Harvard School of Public Health (’97). Since 2006, he is Director of Clinical Research in Newborn Medicine at the
Floating
Hospital
for Children at
Tufts
Medical
Center
. Since 2008, he also serves as Director of the
Pediatric
Clinical
Research
Center
at the
Floating
Hospital
. Dr Dammann’s academic appointments are as Research Professor of Pediatrics (since 9/06) and Public Health (pending) at Tufts School of Medicine in
Boston
. He also serves as Professor and Director of the Perinatal Neuropidemiology Unit at
Hannover
Medical
School
in
Germany
. His research is concerned with the etiology of brain damage and retinopathy of prematurity in preterm infants. He is co-investigator and member of the steering committee of the ELGAN study, funded by NIH with 21 million dollars to study molecular antecedents of white matter damage in preterm newborns. He is currently funded by NIH (National Eye Institute) to perform ancillary analyses in the ELGAN database to identify placenta characteristics that might help predict the risk for retinopathy of prematurity. In
Europe
, Dr Dammann is the principal investigator of NEOBRAIN, a multinational consortium funded by the European Union with 3.5 million Euros to study neuroprotective strategies in preterm newborns. Most recently, another consortium in the EU directed by Dr. Dammann received 2.99 million Euros in funding from the EU to study the developing blood-brain barriers (NEUROBID). Dr. Dammann currently serves on the editorial boards of the journals ”Early Human Development”, “Neonatology”, and “Acta Paediatrica”. His bibliography lists more than 100 published papers.
|
Uma Reddy, MD
Uma M. Reddy, M.D., M.P.H., joined the Branch in September 2003. Board certified in obstetrics and gynecology and maternal-fetal medicine, she was a Robert Wood Johnson Clinical Scholar and received her master’s in public health from Johns Hopkins University. Dr. Reddy completed her obstetrics and gynecology residency at the Johns Hopkins Hospital and her maternal-fetal medicine fellowship at Thomas Jefferson University Hospital. Dr. Reddy manages translational and clinical research grants in obstetrics and maternal-fetal medicine and serves as a program scientist for the Stillbirth Collaborative Research Network (SCRN) and the GPN/PBR. Dr. Reddy is a fellow of the American College of Obstetricians and Gynecologists (ACOG), a member of the Society for Maternal-Fetal Medicine, and a maternal-fetal medicine specialist at National Naval Medical Center.
|
|
Back to Top
Susan J. Vannucci, Ph.D.
Dr. Vannucci received her BS from the
University
of
Michigan
and her MS and PhD from
Pennsylvania
State
University
. Currently, she is a Professor of Neuroscience in Pediatrics/ Newborn Medince at Weill Cornell Medical College. Her research focuses on cerebral metabolism, brain nutrient transport and stroke in a variety of experimental animal models in neonates and adults. Each of the models has direct clinical relevance to conditions including perinatal asphyxial brain damage and diabetic stroke. Cerebral hypoxia-ischemia, or stroke, causes cell death and brain damage due to cellular energy failure and the initiation of a cascade of events including excitotoxicity, apoptosis, and inflammation. Providing appropriate and useable fuel to the brain can help alleviate the energy failure and this process is dependent on the nutrient transporter proteins, primarily the glucose transporter proteins (GLUTs) and monocarboxylate transporter proteins (MCTs). The expression of these proteins in the brain changes with normal cerebral development and with pathologic conditions, including hypoglycemia, diabetes, and stroke. Many of Dr. Vannucci’s research projects focus on the development of therapeutic interventions based on energy substrate supplementation to achieve neuroprotection following stroke.
|
Additional information regarding speakers will be posted as it becomes available. Please feel free to contact Dr. Ian Bird, PhD via email at staff@perinatalresearchsociety.org if you have any questions. Click here for the PRS Reimbursement Policies. |